US EditionBaxter Names Andrew Hider as New CEO, Effective September By Investing.com
WATERLOO REGIONAL MUNICIPALITY, ONTARIO, JUL 7 – Andrew Hider, with over 20 years of leadership and a record of tripling stock value at ATS Corporation, will lead Baxter International into its next phase of growth and innovation.
- On September 3, 2025, Andrew Hider will assume the position of president and CEO at Baxter International, following the company's official announcement of his appointment earlier that month.
- Hider will succeed interim CEO Brent Shafer, who will become independent chair, following the vacancy created by José Almeida's February retirement.
- Hider has over twenty years of global leadership experience, including his tenure as the chief executive at ATS Corporation, where he successfully nearly doubled the company's adjusted revenues and increased its stock price threefold.
- Baxter CFO Joel Grade set a 4% to 5% growth target driven by innovation and R&D, with acquisitions like Avidity Science and Paxiom supporting plans.
- Hider has been recognized as the appropriate leader to guide Baxter through its upcoming phase, emphasizing the acceleration of innovation, enhancement of performance, and pursuit of sustainable growth within a context of balanced financial stability.
Insights by Ground AI
Does this summary seem wrong?
11 Articles
11 Articles
All
Left
1
Center
6
Right
2
Baxter International Appoints Andrew Hider As New President And CEO
(RTTNews) - Baxter International Inc. (BAX), a medtech leader, announced Monday the appointment of Andrew Hider as president and chief executive officer (CEO), and a member of its board of directors. Hider will assume his responsibilities at Baxter no later than Sept. 3, 2025, or
Coverage Details
Total News Sources11
Leaning Left1Leaning Right2Center6Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
11%
C 67%
R 22%
Factuality
To view factuality data please Upgrade to Premium
